New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

methods and translational approaches will help address regulatory science challenges. And importantly, the anticipated new pharmaceutical legislation in Europe, which will be the largest reform of ...

Speaking in Paris at an artificial intelligence summit, the vice president gave an America First vision of the technology — ...

The European Union is drawing up plans to simplify rules governing its huge farming subsidy programme, draft documents seen ...

On 29 January 2025, the European Commission published a communication on its Competitiveness Compass for the EU (COM(2025) 30 ...

Explore the latest European AI initiatives highlighted during the AI Action Summit in Paris. View whether they will help ...

In the first in a series of articles on ISO 20022, Euromoney asks international regulators for their views on the statutory ...

The European Commission does not plan to renew debate on draft legislation for handling artificial intelligence when it causes harms, the IAPP's Caitlin Andrews reports.

The Compass aims to address concerns about productivity and maintain Europe’s leading role in sustainable innovation and climate neutrality.

The EU recently welcomed two regulatory frameworks that will significantly impact the cryptocurrency and digital asset space: ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

The Polish Presidency needs to focus on finalising the pharmaceutical package and reducing dependence on medicine imports ...